Dalal Ilan, Tabori Uri, Bielorai Bela, Golan Hana, Rosenthal Eli, Amariglio Ninette, Rechavi Gidi, Toren Amos
Pediatric Infectious, Allergy, Immunology Unit, E. Wolfson Medical Center, Holon, Israel.
Clin Immunol. 2005 Apr;115(1):70-3. doi: 10.1016/j.clim.2004.08.016.
Mutations in both of the recombination activating genes (RAG)1 and RAG2 can lead to either T-B-severe combined immune deficiency (SCID) or Omenn syndrome (OS), two diseases presenting with totally different clinical and laboratory manifestations. The fact that the same mutations can cause either T-B- SCID or OS, even within the same family, lends credibility to the hypothesis that an additional factor (autoantigen or exoantigen) is required in certain circumstances for the development of OS phenotype. We investigated three patients from the same extended family who presented as T-B- SCID due to a homozygous mutation (G1305T) in the RAG2 gene. Our data support the notion that mutated RAG proteins may not always be sufficient to cause OS phenotype, and show evolution from a T-B- SCID into a typical OS phenotype subsequent to parainfluenza 3 virus infection.
重组激活基因(RAG)1和RAG2的突变均可导致T-B重症联合免疫缺陷(SCID)或欧门综合征(OS),这两种疾病具有完全不同的临床和实验室表现。即使在同一家族中,相同的突变也可能导致T-B-SCID或OS,这一事实支持了以下假设:在某些情况下,OS表型的发展需要额外的因素(自身抗原或外源性抗原)。我们研究了来自同一大家庭的三名患者,他们因RAG2基因的纯合突变(G1305T)而表现为T-B-SCID。我们的数据支持这样的观点,即突变的RAG蛋白可能并不总是足以导致OS表型,并显示在感染副流感3病毒后从T-B-SCID演变为典型的OS表型。